Načítá se...
Sofosbuvir/Velpatasvir for the treatment of Hepatitis C Virus infection
Hepatitis C Virus (HCV) infection is major health problem worldwide, with 150 million infected people according to recent epidemiologic estimations. The introduction of direct-acting antivirals made a revolutionary change in the management of HCV infected patients with surprisingly high rates of ant...
Uloženo v:
| Vydáno v: | Acta Biomed |
|---|---|
| Hlavní autoři: | , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Mattioli 1885
2018
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6502110/ https://ncbi.nlm.nih.gov/pubmed/30333452 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.23750/abm.v89i3.7718 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|